917
Views
3
CrossRef citations to date
0
Altmetric
Cell Cycle News & Views

Targeting CDK4/6 to oppose hypoxia-mediated therapeutic resistance

Pages 1241-1242 | Received 15 May 2017, Accepted 19 May 2017, Published online: 29 Jun 2017
 
This article refers to:
The CDK4/6 inhibitor palbociclib synergizes with irinotecan to promote colorectal cancer cell death under hypoxia

Disclosure of potential conflicts of interest

No potential conflicts of interest were disclosed.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.